CETA and IP Law Changes - Daphne Lainson weighs in
December 9, 2016

As previously reported, On October 31, the federal government introduced Bill C-30, an Act to implement the Comprehensive Economic and Trade Agreement.

In a recent Law Times article, Smart & Biggar’s partner Daphne Lainson weighs in on the update and what it means for pharmaceutical patents.

Click here read the article.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

A A A
web design toronto Rebel Trail